Stock Price
8.49
Daily Change
-0.06 -0.70%
Monthly
10.69%
Yearly
-58.40%
Q3 Forecast
8.48

Prothena reported $56.43M in Operating Expenses for its fiscal quarter ending in June of 2025.




Operating Expenses Change Date
Acadia Pharmaceuticals USD 232.19M 7.16M Jun/2025
Agios Pharmaceuticals USD 139.51M 24.16M Jun/2025
ALKERMES USD 297.68M 4.96M Jun/2025
Alnylam Pharmaceuticals USD 789.89M 213.78M Jun/2025
Amgen USD 6.52B 337M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
BioMarin Pharmaceutical USD 548.52M 27.27M Jun/2025
Exelixis USD 354.68M 13.9M Jul/2025
Incyte USD 904.7M 56.97M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
MacroGenics USD 59M 23.06M Jun/2025
Neurocrine Biosciences USD 541.9M 7M Jun/2025
Prothena USD 56.43M 10.59M Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Ultragenyx Pharmaceutical USD 274.38M 7.85M Jun/2025
Vertex Pharmaceuticals USD 1.81B 71.4M Jun/2025